Neuroinflammation contributes to many neurologic disorders including Alzheimer's disease, multiple sclerosis, and stroke. Microglia is brain resident myeloid cells and have emerged as a key driver of the neuroinflammatory responses. MicroRNAs (miRNAs) provide a novel layer of gene regulation and play a critical role in regulating the inflammatory response of peripheral macrophages. However, little is known about the miRNA in inflammatory activation of microglia. To elucidate the role that miRNAs have on microglial phenotypes under classical (M1) or alternative (M2) activation under lipopolysaccharide ('M1'-skewing) and interleukin-4 ('M2a'-skewing) stimulation conditions, we performed microarray expression profiling and bioinformatics analysis of both mRNA and miRNA using primary cultured murine microglia. miR-689, miR-124, and miR-155 were the most strongly associated miRNAs predicted to mediate pro-inflammatory pathways and M1-like activation phenotype. miR-155, the most strongly up-regulated miRNA, regulates the signal transducer and activator of transcription 3 signaling pathway enabling the late phase response to M1-skewing stimulation. Reduced expression in miR-689 and miR-124 are associated with dis-inhibition of many canonical inflammatory pathways. miR-124, miR-711, miR-145 are the strongly associated miRNAs predicted to mediate anti-inflammatory pathways and M2-like activation phenotype. Reductions in miR-711 and miR-124 may regulate inflammatory signaling pathways and peroxisome proliferator-activated receptor-gamma pathway. miR-145 potentially regulate peripheral monocyte/macrophage differentiation and faciliate the M2-skewing phenotype. Overall, through combined miRNA and mRNA expression profiling and bioinformatics analysis we have identified six miRNAs and their putative roles in M1 and M2-skewing of microglial activation through different signaling pathways.
Introduction
Inflammation is a dynamic and complex process triggered by tissue insult in any region of the body including the central nervous system (CNS) [1, 2] . The first line of defense is mediated through cells comprising the innate immune system that recognize specific molecular motifs and patterns of foreign invaders [3] . The innate immune system then activates adaptive immunity through antigen presentation to boost the response to a specific target [3] . While the two wings of the immune system function in the CNS as well as in the periphery, there are significant differences in both the sequence of events and the cells recruited to the region affected by the insult in the CNS, primarily due to the presence of blood brain barrier (BBB) [1, 3] . Specifically, the CNS relies much more on innate immunity mediated through microglia, monocytes and macrophages while recruitment of neutrophils and T-cells, which mediate adaptive immunity, is limited [3] [4] [5] .
Peripheral macrophages display plasticity characterized by their phenotypic response to pathogenic stimuli, such as ''classical activation'' (M1) phenotype characterized by both pro-recruitment and formation of cytotoxic reactive oxygen/nitrogen species. The other known phenotype is ''alternative activation'' (M2), which exhibit enhanced phagocytosis of apoptotic bodies, anti-inflammatory, and wound healing properties [6] [7] [8] [9] [10] [11] . The M1 phenotype appears as the default response to lipopolysaccharide (LPS), a prototypical Toll-like receptor 4 (TLR4) ligand, and other proinflammatory cytokine stimuli [6, 7] . However, pre-treatment of macrophages with various M2-promoting cytokines can influence the responsiveness to various M2 subtypes such as a pro-cleanup phenotype (M2a) with enhanced phagocytic capability of apoptotic bodies by interleukin-4 (IL-4)/IL-13 stimulation, or woundhealing phenotype (M2c) by IL-10, transforming growth factor-b (TGF-b) or corticosteroid stimulation [6, 7] .
In the CNS there is a growing appreciation for the role neuroinflammation contributes in neuropathogenesis of neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), stroke, human inmmunodeficiency virus (HIV)-associated dementia and psychiatric illnesses such as depression [12] [13] [14] [15] [16] . Microglia, originally described by Pio Del Rio-Hortega in 1932, are generally accepted as the resident member of the mononuclear phagocytes in the CNS and have emerged as the driver of the neuroinflammatory response and wound healing [17] . Microglia were initially thought to exist in two states: a ''Resting'' state with a ramified, branched morphology or an ''Activated'' state with an amoeboid morphology upon detection of pathogenic stimulation [17] [18] [19] . Current research suggests that microglia display a similar dynamic phenotypic response to either pathogenic or cytokine stimulation similar to peripheral macrophages, ranging from an M1-like pro-inflammatory activation phenotype to the M2-like alternative activation phenotype [6] [7] [8] [9] [10] [11] 20, 21] . Colton et al., showed that application of IL-4/IL-13 can equally skew microglia into an M2-like alternatively activated state [8] . Further, Fenn et al., demonstrated enhanced M1 skewing in aged versus adult microglia in an LPS challenge paradigm [20] . Currently, we have limited knowledge in comprehensive characterization of phenotypic activation of microglia.
MicroRNAs (miRNA) are one class of non-coding RNAs that regulate specific gene expression post-transcriptionally and play critical roles in broad biological systems, such as embryogenesis, neural and immune system development, host defense mechanism, and carcinogensis [22, 23] . Recently, the role of miRNAs in regulation of the acute inflammatory response has acquired significant attention with the demonstration that a number of miRNAs are significantly enhanced upon different TLR stimulations in peripheral macrophages, notably miR-155 and miR-146a among others [24] [25] [26] . Recently, Ponomarev et al. demonstrated a key role of miR-124 in microglial differentiation and its ability to suppress inflammatory response of infiltrating macrophages in an experimental autoimmune encephalitis mouse model [27] . However, little is known about the global miRNA response under M1 or M2-skewing conditions in microglia.
The aim of this study was to determine the role that miRNAs have on influencing microgial phenotypes under M1 and M2a skewing conditions. To accomplish this we performed genomewide gene and miRNA expression analyses using primary cultured murine microglia skewed either to M1 or M2a conditions and compared them to resting microglia (M0). To our knowledge this is the first bioinformatics correlation study of miRNA-mRNA expression profiles obtained from M1 or M2a-skewed primary microglia.
Materials and Methods

Primary Culture of Murine Microglia by Percoll gradient centrifugation
All experimental procedures using animals were approved by Institutional Animal Care and Use Committee at Boston University School of Medicine. Microglia were cultured as previously published [28] . Briefly, primary microglia were isolated from P0 or P1 pups from pregnant female CD-1 mice purchased from Charles River Laboratories (Wilmington, MA). Each pup was euthanized for brain isolation. After removal of meninges tissue was minced for 15 minutes with sterile razor blades. The minced tissue was subjected to two serial digestions using 0.25% trypsin (Invitrogen, 25200) and 0.5% deoxyribonuclease I (DNase-I) from bovine pancreas (DN25, Sigma-Aldrich, St. Louis, MO) and trituration by pipetting. Cellular suspension was filtered through a 70-mm pore size nylon cell strainer (352350, BD-Falcon, San Jose, CA), and subjected to density gradient centrifugation for 40 minutes at 200 x g using PercollH (GE Healthcare, 17-0891-01, Fairfield, CT) using a 70% | 37% | 30% | 0% as previously described [29] . Microglia were primarily aggregated +/-,1 ml from the 70-37% layer separation and were then washed two times with PBS to remove any residual Percoll TM before counting and plating. Cells were plated at a concentration of 2610 6 cells/ well of non-coated 6-well plates in Dulbecco's modified essential media with high glucose (DMEM), 10% fetal bovine serum, 100 U/ml penicillin and10 m/ml streptomycin (all from Life Technologies Corporation/Invitrogen). The plate was incubated for 1 hour at 37 uC in 5% CO 2, and the non-adherent cells (mixed glial cell fraction) were removed from the plate. The adherent cells on the original plate comprise the enriched primary microglia, which is cultured for 5 days in the presence of 10 ng/ml recombinant murine granulocyte macrophage-colony stimulating factor (GM-CSF) (CTK-222, Abazyme, Cambridge, MA) and 10 ng/ml murine macrophage-colony stimulating factor (M-CSF) (CTK-308, Abazyme). We observed .85% enrichment of microglia ( Fig. S1A) with minimal neuronal or astrocytic contamination using this approach.
Primary Microglia Isolation by Magnetic Bead Separation
To enhance the purity of the microglia we performed magnetic bead isolation using CD11b Microbeads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) according to the manufacturer's procedure [30] . Briefly, P0-1 pups from pregnant female CD-1 mice were euthanized and their brains were isolated. A single cell suspension was prepared using neural tissue dissociation protocol (130-093-231, Miltenyi Biotec) and gentleMACS TM Dissociator (130-093-235, Miltenyi Biotec). The microglia in the isolated single cell suspension were captured with CD11b MicroBeads (130-093-634) for 15 min at 4 uC. After washing excess unbound beads by centrifugation of cells, the cells were passed through a single MS column (130-042-201, Miltenyi Biotec), which is preset on the OctoMACS TM magnetic Separator (130-042-108, Miltenyi Biotec) and washed three times to remove any unlabeled cells. The washed MS column was removed from the OctoMACS and the microglia was eluted in PBS. Recovered cells were then cultured for 5 days in the tissue culture with both M-CSF and GM-CSF as described above. We observed .93% purity in recovered microglia (Fig S1B) .
Stimulation and RNA Isolation
The primary cultured microglia were placed in serum free media overnight and then stimulated with 100 ng/ml purified LPS (055:B5 Escherichia coli, L2880, Sigma-Aldrich), 20 ng/ml recombinant murine IL-4 (CTK282, Abazyme), or equal volume of PBS for 4 hrs at 37uC with 5% CO 2 . To extract total RNA (combined mRNA and miRNA) samples, the cells are washed once with PBS and then lysed using QIAzolH Lysis Reagent (79306, Qiagen, Germantown, MD) and then isolated using the miRNeasyH Mini Kit (217004, Qiagen) using the automated RNA purification instrument (QIAcubeH, 9001292, Qiagen). The isolated RNA is checked for quality by RNA agarose gel electrophoresis, 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), having a minimum 260/280 ratio of 1.80 or greater, and then quantified using NanoDrop 1000 (Thermo Scientific, Waltham, MA).
mRNA gene expression and miRNA expression Profiling Microarrays
For mRNA expression profile, samples were tested on the Affymetrix GeneChip Mouse Exon 1.0 ST Array (900818, Affymetrix, Santa Clara, CA) which targets more than 28,000 annotated genes with over 835,897 distinct probes (approximately 40 probes per gene). For total miRNA expression profiling, samples were tested on the Mouse GeneChip miRNA 2.0 Array (901754, Affymetrix) that interrogates 690 murine pre-miRNAs and 722 murine mature miRNAs, which provides complete coverage of miRBase v15, including both mature and hairpin stem loops. Both mRNA and miRNA expression profiles were performed by Microarray Core facility at the Boston University School of Medicine. The GeneChip data files were deposited to the NCBI Gene Expression Omnibus (GEO) repository with accession numbers of GSE49329 and GSE49330 for the mRNA and miRNA expression profiles, respectively.
Microarray data analysis
To identify pathways and functions previously ascribed to the differentially expressed mRNAs and miRNAs, expression data files were analyzed using IngenuityH Pathway Analysis (IPA) tool, a commercially available web-delivered bioinformatics tool (Ingenuity Systems, Redwood City, CA) [31, 32] . Ingenuity functional analysis, canonical pathway analysis, and transcriptional factor analysis were identified by performing IPA core analysis of log2 fold change for LPS or IL-4 stimulated group versus un-stimulated group. For detailed explanation of the IPA core analysis employed please see Materials and Methods S1.
Identification of miRNA Target datasets
To identify potential miRNA-mRNA interaction profiles we combined publically available miRNA prediction target databases, including miRanda database (http://www.microrna.org) and Ingenuity Systems which combines TargetScan (http://www. targetscan.org) and TarBase (http://diana.cslab.ece.ntua.gr/ tarbase/) [33] [34] [35] . Select differentially regulated miRNAs were correlated with observed gene expression differences and then compared with predicted targets of the miRNA using publically available Gene List Venn Diagram software [36] (http:// simbioinf.com/mcbc/applications/genevenn/genevenn.htm).
Validation of differentially regulated miRNA and mRNA from the genome-wide microarray Based on the results of the microarray analysis, select miRNA and mRNA targets were verified by real-time reverse transcription Polymerase Chain Reaction (RT-PCR). We used RNA samples (n = 4) for each stimulation condition from the same RNA used for the miRNA and mRNA microarray testing. mRNA RT-PCR was performed using QuantiTect Reverse transcription kit (205311, Qiagen) for cDNA synthesis, QuantiFast SYBR Green RT-PCR Kit (204154, Qiagen) for real-time PCR, and custom designed primers for target genes (Invitrogen) (see Table S1 for primer sequences for all genes probed). miRNA RT-PCR was performed using miRCURY Locked Nucleic Acid (LNA) TM Universal cDNA Synthesis Kit (203300, Exiqon, Vedbaek, Denmark), miRCURY LNA TM SYBR Green master mix RT-PCR Kit (203450, Exiqon) and specific primers to mmu-miR-155, mmu-miR-124 and mmumiR-146a (#205080, #204319, and #204688, Exiqon, respectively). All RT-PCR reactions were conducted using the real-time thermal cycler (MastercyclerH ep realplex 4, Eppendorf).
Statistical Analysis
All data were normally distributed and presented as mean values 6 SEM. In the case of single mean comparisons, data was analyzed by Students t-test. In the case of multiple mean comparisons one-way analysis of variance and Tukey's post hoc or two-way repeated measures analysis of variance was used (Prism 4.0, Graphpad Software, San Diego, CA, USA). P-values , 0.05 were regarded as significant. Statistical analysis on microarray data was performed with the aid of Boston University School of Medicine's Microarray Core facility performing Students t-tests on miRNA and gene expression arrays, as well as Pearson's correlation coefficient between select miRNAs and gene expression.
Results
Differentially expressed genes in LPS (M1-skewing) and IL-4 (M2a-skewing) stimulated Primary murine microglia
Resting, M1-classical, or M2-alternative skewing of primary murine microglia was achieved by stimulation of serum-starved cells with PBS, LPS, or IL-4 respectively (Fig. S1C ). Cells were then lysed and total RNA was isolated, which includes both mRNA and miRNA. The isolated total RNA was subjected to quality examination and samples of high quality RNA were subjected to Affymetrix Mouse Exon 1.0 ST Array for mRNA expression profiling. M1-skewed primary microglia differentially regulated a total of 4275 genes out of total 28,853 genes to a significance of p , 0.0001, where 2477 genes (58%) were upregulated and 1798 genes (42%) were downregulated ( Table 1) . A differential mRNA expression profile is presented as heat map, highlighting 63 genes that were differentially regulated to a significance determined by a moderated FDR q , 1610
27 as compared against resting microglia (Fig. 1A) . Consistent with previous reports in both microglia and macrophages, we found the IL-6 gene to be the most upregulated gene upon LPS stimulation, showing 425-fold increase relative to resting cells (Fig. 1B) [37, 38] . Along with IL-6, the expression of many other canonical M1-marker genes in peripheral macrophages, e.g. IL-12a, NOS2, and IL-1b, are hichly enhanced by LPS stimulation of microglia ( Fig  1B) [37, 38] . To validate our microarray results we performed mRNA RT-PCR using total RNA isolated from the same samples on select M1-marker genes, and confirmed that expression of IL-6, IL-1b, and NOS2 genes were significantly induced upon LPS stimulation (Fig. 1D) . Further, we also demonstrated a significant expression of TNF-a gene (Fig. 1D) , which showed 28-fold induction in our mRNA microarray dataset (data not shown). To minimize the potential that these findings included the gene expression profiles of mixed glial cells we performed a second isolation using CD11b magnetic beads and column isolation, as described in Methods. We observed similar induction of in IL-6, TNF-a and IL-1b upon LPS stimulation, which correlated well with the overall tendencies (r 2 = 0.72) when compared with our initial findings ( Fig. 1E and S2A ). Further, these findings are consistent with the transcriptional profiles of the M1-skewed peripheral macrophages [39] . Taken together, these data demonstrates classical M1-skewing of microglia by LPS.
We next characterized the gene expression profile of M2-skewed microglia by IL-4 stimulation. A total of 1606 genes were differentially regulated to a significance of p,0.0001, where 905 genes (56%) were up-regulated and 701 genes (44%) were downregulated (Table 1) . We observed the Chitinase-3 Like 3 (CHI3L3) gene, a known M2-marker in peripheral macrophages, as the most 1C ) [8, 40] . Further, we observed enhanced expression of other M2-markers including RETNLA (FIZZ1) and arginase 1 (ARG1, Fig. 1C ) [8, [40] [41] [42] . To validate the microarray results we performed real-time RT-PCR on select genes and confirmed that gene expression of both CHI3L3 and ARG1 were significantly increased upon IL-4 stimulation (Fig.  1C) . We also tested microglia isolated by magnetic bead isolation for IL-4 stimulation, and confirmed similarly enhanced expression of ARG1 (5.8-fold increase by Percoll-isolated microlia and a 4.2-fold increase by magnetic bead isolated microglia, Fig. 1E and S2A). These findings are comparable to the gene transcription profile of M2a-skewed peripheral macrophages [43] . Taken together, these data demonstrate alternative activation of M2-skewed microglia [11, 44] .
Differentially expressed miRNA in LPS and IL-4 stimulated microglia
We next sought to identify miRNAs differentially expressed in the resting, M1-or M2-skewed microglia. The same RNA samples tested for mRNA expression profiling were tested for miRNA microarray expression profiling using the Affymetrix Mouse GeneChip miRNA 2.0 Array. The miRNA expression profile is presented in heat-map by highlighting the top 50 miRNAs (p , 0.05 as determined by Student's t-test vs. resting microglia, Fig.  2A ). During LPS stimulation, the expression of 47 out of 722 miRNAs was significantly changed; 12 (26%) miRNAs were significantly increased and 35 (74%) were significantly reduced (Table 1) . Interestingly, IL-4-stimulated microglia significantly changed the expression of 44 miRNAs (p,0.05): 16 (36%) miRNAs were increased and 28 (64%) mRNAs were decreased (Table 1) .
Under LPS stimulation of microglia, miR-155 was the most significantly up-regulated miRNA (9.69-fold increase vs. PBS control, p,0.01, Fig. 2B ). Other significantly increased miRNAs in M1-skewed microglia include: miRs-297b-5p, -302c, -191*, -10b, -105, -495, -7a, -670, -1934, -201, -200c*, -214*, -673, and -141* (Fig. 2B) . Further, we also observed significant reduction in the expression of miRs-1928, -3474, -383, -192, -1939, -466b-3p, -2134, -1901, -762, -689, -128*, -542, -700, -219, and -705 (p,0.05) (Fig. 2C) . We next performed LNA-based real-time RT-PCR and confirmed that miR-155's expression is significantly increased upon LPS stimulation (43-fold increase, p , 0.01, Fig.  2D ). To validate our results we performed the LNA-based RT-PCR of miR-155 using magnetic bead isolated microglia, and saw a similar increase in miR-155 expression after 4-hour LPS stimulation ( Fig. 1E and S2B) .
In IL-4 stimulated microglia we observed miR-145 as the most increased miRNA (2.66-fold) along with miR-297b-5p and miR-214 (all greater than 2.0-fold increase, p,0.05, Fig. 2E ). (Fig. 2F) .
Overall, we have identified miRNAs miR-155 and miR-145 as the most significantly up-regulated miRNAs in the M1 or M2a-skewed microglia, respectively. Further, we also have identified significant down-regulation of miR-689 and miR-711 in the M1 or M2a skewed primary microglia, respectively.
Systems Biological analysis of differentially expressed genes in LPS (M1-skewing) and IL-4 (M2-skewing) stimulated Primary murine microglia
To characterize how the gene and miRNA expression in different activation states alter microglial functionality, the enrichment pathway analysis was performed using the IngenuityH Pathway Analysis (IPA) tool [31, 32] . Microglia altered 54 biological functions under the M1-skewing condition. The top 10 up-or down regulated biological functions are identified ( Fig.  S3A and S3B) . Consistent with our expectations, IPA analysis identified the ''Inflammatory Response/Immune Response'' Fig. S3A ). Further, microglia altered 66 biological functions under the M2a-skewing condition; the top 10 up-regulated and down regulated biological functions are identified (Fig. S3C and S3D ). IPA analysis also identified the function ''Inflammatory Response/Immune Response'' as the most significantly up-regulated function enriched with over 84 genes in M2-skewing condition (p,3.70610 -26 , Fig S5C) . In fact, IPA analysis identified that nine out of the top ten functions for both skewing conditions fall in the same categories, leading us to question if these are unique phenotypes (Fig S3A and S3C) . To determine if M1-skewing and M2a-skewing actually activated distinct sets of genes, we compared the enriched gene sets from the IPA analysis for both conditions that comprised the ''Inflammatory Response/Immune response'' function. We found only 33 common genes out of a total of 292 genes (Fig. S3E) . From those observations, we concluded that while the top 10 up-regulated functions fall in the same categories between the two phenotypes, each common function comprises mostly distinct genes and ultimately represent a unique phenotype.
We next looked at the alterations in the transcriptional networks in M1-or M2a-skewed microglia. The IPA tool makes predictions of transcriptional networks based on statistical analysis of how a given condition alters both the transcription factor and its downstream targets (see Materials & Methods S1 for detailed description). LPS stimulation demonstrated many well characterized pro-inflammatory transcription factors as the most significantly ''activated'' genes, including: NF-kB (NFkB1-RelA), Activating Protein-1 (AP-1), Signal Transducer and Activators of Transcription (STAT 1-4), and Interferon Regulatory Factors (IRF 1, 3, 7 and 8, Fig. 3A-D) . Nine other significantly ''activated'' transcription factors are associated with the pro-inflammatory state of either microglia or macrophages (Fig. 3A) . We next characterized the underlying transcriptional regulators in IL-4 stimulated microglia. Consistent with canonical IL-4 signaling, STAT6 was the most significantly ''activated'' transcription factor (p,6.06610 -16 , Fig. 3A) . Interestingly, there were significant reductions in expression of STAT1, STAT3, STAT4 and IRF3a gene, which all play critical roles in TLR4 signaling (Fig. 3A) . Under IL-4 stimulation, we also detected modest but statistically significant up-regulation of many transcription factors that were also seen by LPS stimulation including: NF-kB (NFkB1-RelA), Jun, ERG1, CEBPB, and IRF1 (Fig. 3B) . Interestingly, under either LPS or IL-4 stimulation, we commonly observed significant suppression of many nuclear receptor family members, including peroxisome proliferator-activated receptors (PPAR) family, nuclear receptor 1H (NR1H) family, thyroid hormone receptor-b (THRb) and retinoid x receptor-a (RXRa, Fig. 3C ). This is consistent with recent findings that alterations in the nuclear receptor family contribute to microglial activation [45, 46] . However, most importantly we identified genes that are actively suppressed by LPS stimulation and conversely increased by IL-4 stimulation: STAT6, Tripartite motif-containing 24 (TRIM24), cyclic AMP response element-binding-1 (CREB1), IRF2 and PPARa/c genes (Fig 3D) , which may represent key molecules which direct M2-skewing of microglia.
Target analysis of key miRNA/mRNA interactions identified in LPS-stimulated murine primary microglia
To better identify potential miRNA-mRNA interactions that regulate transitions between the different microglia phenotypes, we performed a correlation analysis between select miRNAs and the mRNA expression data sets. To further identify potential miRNA-mRNA interactomes, we next compared the correlated gene sets to potential gene targets of specific miRNAs, identified through use of commercially available target databases, e.g. miRanda, TargetScan (ver 6.0) and TarBase (Fig. 4A) [33] [34] [35] . We applied this approach to 22 miRNAs representing the most up-or down-regulated miRNAs under M1-skewing conditions (Table S2 ). On average we observed an 18% overlap between significantly correlated and differentially regulated gene sets when compared our gene expression database against the miRanda database of predicted targets. However, when compared with TargetScan predicted target genes, we observed only 6% overlap between significantly correlated and differentially regulated gene sets (Table S2 ). The intersection of all three data sets is the potential candidate target gene set, which represents 3% of the originally differentially regulated genes (Table S2 ). We applied this methodology to the following up-regulated miRNAs under LPS stimulation: miR-155, -297-5p, -302c, -10b, -495, -7a, -376a, -539, and -876-5p and the following down-regulated miRNAs under LPS stimulation: miR-124, -2132, -2122, -143, -219, -700, -689, -762, -1901, -466b-3p, -192, -383, -3474 and -1928. Using miR-155 as an example of this methodology to identify potential miRNA:mRNA interactome, we first identified 4231 genes that were strongly correlated with miR-155 expression and significantly differentially expressed under LPS stimulation (p,0.0001). We then compared the identified genes to the 1081 genes identified as potential miR-155 targets by targeScan/IPA database, and to the 3329 genes identified as predicted miR-155 targets by the miRanda database. The intersection of these three data sets netted a total of 112 potential miRNA-155:mRNA interactions, of which 16 were previously validated targets of miR-155 ( Fig. 4B and Table 2 ). Interestingly, of the 112 potential miR-155 targets 68 were down-regulated and inversely correlated with the expression of miR-155, suggesting direct regulation by miR-155. The remaining 44 identified candidate targets were rather up-regulated and positively correlated with the expression of miR-155, including a number of known targets of miR-155, e.g. Suppressor of Cytokine Signaling-1 (SOCS1), hypoxic inducible factor 1-alpha (HIF1a) and CCAA/enhancer binding protein-b (CEBPb) (Fig. 4B and Table 2 ). Most other predicted targets of specific miRNAs were evenly split (50/50) between those targets inversely correlated to their respective miRNA, as expected, versus those targets that were positively correlated with their respective miRNA (data not shown). This observation is consistent with previous miR-NA:mRNA correlation observations [47] .
To determine how each miRNA potentially contributes in shaping the M1-or M2-phenotype of microglia, the second IPA enrichment analysis was performed using our lists of potential miRNA:mRNA interactions. miRNAs were selected based on a combination of p-values and an average expression level of greater than 50% as referenced to miR-709, the highest expressing miRNA in microglia in all three groups. M1-skewing of microglia yielded four up-regulated miRNAs: miR-155, -297b-5p, -10b, and -376a and six down-regulated miRNAs: miR-124, -2132, -2133, -700, -689, and -762. By combining the correlated miRNA:mRNA interactions from all of the miRNAs and the IPA transcriptional factor analysis, we observed over 153 transcriptional networks that are potentially altered though these miRNA:mRNA interactions (Fig 4C and Table S3 ). Interestingly, down-regulation of miR-689 and miR-124 appears to have more impact on these gene transcriptional networks than the up-regulation of miR-155 based on the -log (p-value) from the IPA enrichment analysis (Fig. 4C and Table S3 ). miR-689 potentially alters the transcriptional networks of many canonical pro-inflammatory pathways including NF-kB-RelA and NFATC2/3. Further, miR-124, a miRNA known to alter microglial phenotypes [27] , was identified as potentially regulating ELK4, NCOA3, NFE2L2, and STAT1 transcriptional networks in this analysis. miR-155 potentially regulates three transcriptional networks, the most significant being STAT3, HOXA9, and CEBPb (Fig 5C) .
Collectively, we have observed a set of miRNAs for M1-skewed microglia and identified the potential transcriptional targets of miR-155. Further, our second IPA analysis identified downregulation of both miR-689 and miR-124 as playing potential key roles in M1-activation of microglia. Overall, our data suggests that down-regulation of miRNAs, e.g. miR-689 and miR-124, may 'release' microglia from the M0 state, and up-regulation of miR-155 contribute to the establishment of the M1-skewing.
Target analysis of key miRNAs identified in IL-4 stimulated murine primary microglia
We applied the same approach to identify key potential miRNA:mRNA interactions that regulate switching microglia from M0 to M2a phenotype. Overall, 20 different miRNAs that represent the most up-or down-regulated miRNAs under M2a skewing conditions were analyzed (Table S4) . Interestingly, 1608 genes were significantly differentially regulated (p,0.0001) by IL-4 stimulated condition with similar overlap percentages as LPS stimulated condition: 13.27% overlap with the miRanda database, 6.90% overlap with IPA-provided database, and a combined overall overlap of 3.28% (Table S4 ). To identify critical potential miRNA:mRNA interactions that regulate switching from the M0 to the M2a phenotype we performed correlation analysis on the following up-regulated miRNAs: miR-449a, -295, -145, -297-5p, and -214 and the following down-regulated miRNAs: miR-124, -154*, -2133, -384-5p, -2135, -3473, -326, -2132, -133, -383, -2861, -2138, -762, -1224 and -711. Overall, this process identified 724 potential targets, representing 66% of correlated genes under IL-4 stimulation of microglia that are potentially regulated by miRNA:mRNA interactions.
Using the same screening criteria as described above, we performed the second IPA enrichment analysis on four upregulated miRNAs upon IL-4 stimulation: miR-145, -214, -297b-5p, and -449a and nine are down-regulated miRNAs: miR-711, -124, -2133, -2135, -2132, -2861, -2138, -762, and -1224. Under M2a-skewing conditions we identified over 268 transcriptional networks that are potentially altered by miRNA:mRNA interactions. Interestingly, down-regulation of miR-711 or mir-124 are as significant as up-regulation of either miR-145 or miR-449a in establishing the M2a phenotype based on -log(p-value) score ( Fig  4D and Table S5 ). miR-711 appears to alter the transcriptional networks of many canonical pro-inflammatory pathways including NF-kB-RelA, IRF1/2, SP1, IkB, and AP1 (Fig 4D and Table S5 ).
Collectively, we have identified a set of miRNAs for M2a-skewed microglia, which may play a critical role in the IL-4 response. Further, our second IPA analysis identified that downregulation of miR-711 or miR-124 may play a key role in 'releasing' microglia from the M0 state, and up-regulation of miR-145 may contribute to establishment of the M2a state.
Discussion miRNAs in M1 and M2a phenotypes
In the present study, we systematically identified key miRNAs and their potential role in regulating murine microglial M1 or M2-skewed activation. To the best of our knowledge this is the first genome-wide study combining both mRNA and miRNA expression profile of primary cultured murine microglia.
We identified mmu-miR-155 as the primary miRNA induced upon M1-skewing of microglia. Interestingly, miR-155 plays a key role in regulating the acute innate immune response in peripheral macrophages [24, 25, 48, 49] . In addition, in peripheral macrophages, miR-155 is strongly induced upon several TLR ligands, as well as bacterial or viral infection, oxidized LDL, TNF-a, and primary cultured microglia and in the N9 microglial cell line [50] . Our study demonstrated that miRNA prominently altered in the M1-skewed microglia is limited to miR-155 and any other miRNAs, e.g. miR-10b and miR-297b-5p are only modestly altered (, 2-fold change). miR-155 is likely to be the key miRNA that mediates an acute pro-inflammatory state in primary microglia, demonstrating that miR-155 is an apparent therapeutic target for M1-skewed microglia-related neurologic disorders.
IL-4 stimulation is known to induce alternative activation in primary microglia [8] . We observed several miRNAs that are significantly up-regulated in IL-4 stimulated primary microglia, including miR-145 and mir-214. The association of miR-145 or miR-214 with the IL-4/STAT6 signaling pathway has never been reported in microglia. Interestingly both miR-145 and miR-214 are anti-oncogenic miRNAs [51] [52] [53] [54] . Supporting a role for miR-145 in the IL-4/STAT6 signaling, Collison A. et al. have recently demonstrated that miR-145 inhibition is as effective as steroid treatment in animal models of allergic airway disease, a disease mediated by IL-4 induced Th2 skewing disorder [55] . miR-214 has no known roles in either microglial or macrophage biology. However, Jindra, PT et al. reported a role for miR-214 in T cell proliferation [56] , suggesting a similar function as miR-145.
Critical regulators determining microglial phenotypes
Since miRNAs are known to regulate entire 'batteries' of genes leading to phentotypic switches, we first sought to identify key regulatory networks and transcriptional pathways that are altered between different phenotypic states in microglia [57] . M1-skewed microglia demonstrated activation of many well-characterized proinflammatory transcriptional networks, including NF-kB, AP-1, STAT 1-4, and IRF 1,3,7, and 8 [58] [59] [60] . On the other hand, M2a-skewed microglia demonstrated a unique activation of pathways primarily though IL-4 signaling molecules including STAT6, CREB1 and IRF2 [61] [62] [63] . Further, we observed differential regulation of the JAK/STAT transcriptional networks: M1-activation suppresses the STAT 6 network, while M2a-activation suppresses STAT 1-4 networks (Fig 3A) . Lastly, we observed profound suppression of the nuclear receptor family pathways under both M1 and M2-skewing conditions, suggesting the suppression of their activity to release microglia from the M0 state.
JAK/STAT Signaling in Microglial Activation
We observed significant differences in the transcriptional regulation between LPS and IL-4 stimulation in microglia, particularly in the activation patterns of the JAK/STAT pathways. At the four-hour time point, STAT3 and STAT1 signaling dominate the active transcriptional network in LPS stimulated microglia. This is consistent with similar observations in peripheral macrophages stimulated with LPS that demonstrate marked reductions in NF-kB signaling after ,2 hours and strong up regulation of STAT1/STAT3 signaling [59, 60] . The neuroinflammatory role of STAT3 in microglia has been suggested by multiple studies as inhibition of STAT3 mitigates LPS-induced activation of microglia [64, 65] . Further, to underscore the prominence of STAT3, Qin, H. et al. recently demonstrated that a conditional knockout of SOCS3, an endogenous STAT3 antagonist, increases the severity of EAE [66] . Our study shows that STAT3/STAT1 axis is one of the primary activating signal pathway in LPS-stimulated microglia at the 4 hr time point.
While STAT3 and STAT1 help establish the M1-skewing of microglia, M2a-skewed microglia are facilitated by STAT6 signaling pathway [61, 67] . Under IL-4 stimulation, microglia show strong activation of the STAT6 signaling pathway (Fig. 3A) .
Interestingly, we also observed strong down-regulation of STAT6 signaling by LPS stimulation, suggesting active repression of the STAT6 pathway may be necessary for M1-skewing of microglia. In accord, under IL-4 stimulation we observed significant inhibition of the STAT1/3 signaling pathways, suggesting repression of STAT1/3 pathway is equally necessary for M2-skewing of microglia. Taken together these data suggest crossinhibition between the STAT1/3 pathways and the STAT6 pathway for efficient M2 or M1-skewing of microglia.
Nuclear Receptor Alterations in Microglial Activation
Under either M1 or M2a-skewing of primary microglia activation we observed marked reductions in the transcriptional activity of many nuclear receptors relative to the M0 resting phenotype (Fig 3C) including: PPARa/c/d, Liver X receptoralpha/beta (LXRa/b), glucocorticoid receptor (NR3C1), and the retinoic acid receptor-alpha (RARa). There is a growing body of literature linking innate inflammatory processes under M1-skewing conditions to reduced activation of the various nuclear receptors, e.g. PPARc/d, RXR and LXR systems [45, [68] [69] [70] [71] [72] [73] . The necessity of reduced nuclear receptor activity in enabling the M1 phenotype is underscored by the ability of PPARc/d, RXR or LXR nuclear receptor agonists to blunt many of the proinflammatory mediators under LPS stimulation [69] [70] [71] 73] . Further, these nuclear receptor agonists have all demonstrated the ability to exert anti-inflammatory activity in peripheral macrophages and reduce macrophage-mediated disorders such as atherosclerosis [74] [75] [76] . In microglia, treatment with nuclear receptor agonists (e.g. PPARa/c, RXR and LXR) has been shown to exert similar anti-inflammatory activity [77] [78] [79] . Recently, Achiron, A. et al. demonstrated dysregulation of the nuclear receptor family in human peripheral blood in pre-disease state of MS, suggesting this is a critical aspect in the progression of MS from pre-clinical to clinical states [45] .
Based on the evidence linking nuclear receptor activation with anti-inflammatory activity, we had originally anticipated that M2a-skewing to up-regulate the activity of the nuclear receptor family. Surprisingly, many of the same nuclear receptors that were down regulated upon M1-skewing were also down regulated in M2a-skewing, albeit to a much lesser extent. However, we observed a critical difference between the M1-skewing and M2a-skewing phenotypes in the activity of the PPARc and RARa transcriptional networks, which both demonstrated a greater than 3-fold difference in activity between the two phenotypes (Fig 4C) . Interestingly, therapeutic application of the PPARc agonists, pioglitazone, has been demonstrated to skew microglia from M1 to the M2 phenotype, reduce amyloid plaque burden, and improve cognitive deficits in the APP/PS1 mouse model of AD [80] . Thus, it is highly likely that phenotypic switch of microglia from M1 to M2-skewed activation is therapeutically relevant for neurologic disorders involving neuroinflammation.
Inferring miRNA's role in regulating M1 and M2 phenotype
We are intrigued that many of our identified miRNA:mRNA interactions, even for validated known target mRNAs of the miRNA, did not always follow the canonical repression paradigm (Table 2) . That is, the target mRNA was up-regulated despite upregulation of an miRNA that has been predicted to interact and repress said target. Conversely, we also observed down-regulation in target mRNA where interacting miRNAs were also correspondingly down regulated. Taken together, this suggests a much more nuanced and complex regulatory mechanism employed, which Shahab, S. et al. recently observed using a similar systems analytical approach in ovarian cancer model [47] .
These studies suggest a more complex scheme of regulation beyond simple down regulation of a target. Indeed, the majority of miRNA regulation is at the post-transcriptional level, and inhibition of translation may up-regulate gene transcription to compensate the reduced expression of target protein by miRNA. Thus, identification of miRNA:miRNA interaction itself may be more relevant than focusing on positive or negative correlation of mRNA:miRNA to elucidate the potential miRNA:mRNA interactome.
Far less is known about the role miRNAs play in shaping the M2a phenotype in either peripheral macrophages or primary microglia. Upon M2a-skewing of primary microglia we observed up-regulation in two miRNAs: miR-145 and miR-214. miR-145 was recently identified as down-regulated in M2-skewed peripheral macrophages as compared to that of M1-skewed macrophages while this paper was being revised [81] . As was observed under LPS stimulation, some miRNAs are down regulated that appear to facilitate initial activation. Specifically, during M2a-skewing downregulation of miR-711 and miR-124 may work in coordination to release microglia from the resting state. miR-711 potentially regulates targets associated with a number of pro-inflammatory pathways including AP1, IRF1/2, NF-kB1-RelA, SP3, Krupplelike factor-2 (KLF2) and PPARc. In accord, PPARc directly regulates alternative activation in peripheral macrophages [82] , and KLF2 directly regulates the pro-inflammatory state in monocytes and facilitates the switch to alternative activation to M2 phenotype respectively [82] [83] [84] , supporting the role of PPARc and KLF2 on M2-skewing.
Overall Summary
Based on our study the following microglial phenotype (state) transition diagram is proposed (Fig. 5) . To establish the M1-skewed activation of microglia, reductions of both miR-689 and miR-124 release microglia from resting (M0) state, and facilitate canonical TLR signal pathways and NF-kB-RelA effector pathways, enabling the initial pro-inflammatory ''recruitment'' M1 phenotype. The swift up-regulation of miR-155 may drive the transition from TLR signal and NF-kB/RelA pathways to STAT1/STAT3 signaling pathways to complete the late-phase elements of the M1-skewed response. For M2-skewed activation, the down-regulation of miRNAs is critical in 'releasing' primary microglia from their M0 state, through down regulation of miR-711 and miR-124, and up-regulation of miR-145 may facilitate establishing the M2a-alternatively activated state. Further studies will be necessary for examining the specific miRNA:mRNA interactions, their roles in activation phenotypes of microglia, and their clinical implications. Figure S1 Microglial Culture Purity and Experimental Scheme. (S1A), murine primary microglial isolated using the PercollH density gradient methodology cultured after 5 days, as describe in section 2.0 materials and methods. Microglia were stained with immunoflorescent antibodies to identify microglia (CD11b, green), astrocytes (GFAP, red), and neurons (MAP2, blue), demonstrating a greater than 85% purity. (S1B), murine primary microglial isolated using the magnetic bead methodology cultured after 5 days, as describe in section 2.0 materials and methods. Flow cytometry assessment of purity by staining isolated primary microglia with anti-CD11b-APC immunoflorescent antibody, demonstrating a greater than 93% purity. (S1C), Experimental protocol scheme, Primary microglia were isolated from P0-P1 pups and cultured 5-7 days. 24-hours prior to stimulation media was changed to serum free media and at time (t = 0) were stimulated with LPS (100 ng/ml), IL-4 (20 ng/ml), or PBS for four hours. Cells were then lysed and total RNA was harvested for both miRNA and mRNA microarray analysis (n = 3 per condition), as well as for mRNA RT 
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